1. Home
  2. LIXT vs VEEE Comparison

LIXT vs VEEE Comparison

Compare LIXT & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • VEEE
  • Stock Information
  • Founded
  • LIXT 2005
  • VEEE 1994
  • Country
  • LIXT United States
  • VEEE United States
  • Employees
  • LIXT N/A
  • VEEE N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • VEEE Marine Transportation
  • Sector
  • LIXT Health Care
  • VEEE Industrials
  • Exchange
  • LIXT Nasdaq
  • VEEE Nasdaq
  • Market Cap
  • LIXT 4.2M
  • VEEE 4.7M
  • IPO Year
  • LIXT N/A
  • VEEE 2021
  • Fundamental
  • Price
  • LIXT $1.62
  • VEEE $0.44
  • Analyst Decision
  • LIXT
  • VEEE
  • Analyst Count
  • LIXT 0
  • VEEE 0
  • Target Price
  • LIXT N/A
  • VEEE N/A
  • AVG Volume (30 Days)
  • LIXT 1.8M
  • VEEE 1.3M
  • Earning Date
  • LIXT 11-12-2024
  • VEEE 11-14-2024
  • Dividend Yield
  • LIXT N/A
  • VEEE N/A
  • EPS Growth
  • LIXT N/A
  • VEEE N/A
  • EPS
  • LIXT N/A
  • VEEE N/A
  • Revenue
  • LIXT N/A
  • VEEE $20,852,002.00
  • Revenue This Year
  • LIXT N/A
  • VEEE $76.99
  • Revenue Next Year
  • LIXT N/A
  • VEEE N/A
  • P/E Ratio
  • LIXT N/A
  • VEEE N/A
  • Revenue Growth
  • LIXT N/A
  • VEEE N/A
  • 52 Week Low
  • LIXT $1.31
  • VEEE $0.33
  • 52 Week High
  • LIXT $4.42
  • VEEE $1.77
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 43.04
  • VEEE 39.83
  • Support Level
  • LIXT $1.56
  • VEEE $0.44
  • Resistance Level
  • LIXT $1.87
  • VEEE $0.52
  • Average True Range (ATR)
  • LIXT 0.23
  • VEEE 0.06
  • MACD
  • LIXT -0.03
  • VEEE -0.00
  • Stochastic Oscillator
  • LIXT 8.33
  • VEEE 15.69

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.

Share on Social Networks: